Danaher Corporation DHR
233.02 USD +0.86 (+0.37%)
At closeNov 13, 2026, 4:02 PM EST
233.02 0.00 0.00%
After hours · Nov 13, 4:02 PM ET
229.92 Day range 233.76
160.93 52-week range 242.80
- YTD
- +1.79%
- 1 year
- +5.34%
Benzinga news
benzinga.com Danaher Companies Integrated DNA Technologies And Aldevron Jointly Launch New Research-Grade mRNA Solutions Designed For Base And Prime Editing Workflows The launch brings IDT’s gene editing expertise and Aldevron’s mRNA manufacturing together within Danaher’s connected ecosystem to address researchers’ increasingly specialized editing needs. Building…
benzinga.com Bill Ackman’s 20-Year Investing Rule Puts These Cash-Flow and Moat ETFs in Focus Bill Ackman’s 20-year investing rule puts cash flow and competitive advantages in focus. See how COWZ and MOAT ETFs stack up amid AI spending fears.
benzinga.com Billionaire Investor Adds to Danaher Stake After Cutting It Earlier This Year Dan Loeb’s Third Point increased its Danaher stake to 540,000 shares in the second quarter, up from 525,000, with a $102.8 million valuation.
benzinga.com Danaher Posts First Earnings Under New CEO; Emphasizes Need For Improved Execution, Innovation Danaher shares fell despite upbeat Q3 results. TD Cowen raised its target, citing tariffs and a cautious 2027 outlook.
benzinga.com Citigroup Maintains Buy on Danaher, Raises Price Target to $270 Citigroup analyst Patrick Donnelly maintains Danaher (NYSE:DHR) with a Buy and raises the price target from $230 to $270.
benzinga.com Danaher Analysts Raise Their Forecasts Following Better-Than-Expected Q3 Earnings Danaher beat Q3 earnings and revenue estimates, raised FY2026 profit guidance, and analysts lifted price targets despite shares falling 1.8%.
benzinga.com Barclays Maintains Overweight on Danaher, Raises Price Target to $260 Barclays analyst Luke Sergott maintains Danaher (NYSE:DHR) with a Overweight and raises the price target from $255 to $260.
benzinga.com JP Morgan Maintains Overweight on Danaher, Raises Price Target to $270 JP Morgan analyst Casey Woodring maintains Danaher (NYSE:DHR) with a Overweight and raises the price target from $250 to $270.
benzinga.com TD Cowen Maintains Buy on Danaher, Raises Price Target to $270 TD Cowen analyst Dan Brennan maintains Danaher (NYSE:DHR) with a Buy and raises the price target from $255 to $270.- benzinga.com Stifel Maintains Buy on Danaher, Raises Price Target to $260 Stifel analyst Daniel Arias maintains Danaher (NYSE:DHR) with a Buy and raises the price target from $220 to $260.
- benzinga.com Baird Maintains Outperform on Danaher, Raises Price Target to $254 Baird analyst Catherine Schulte maintains Danaher (NYSE:DHR) with a Outperform and raises the price target from $246 to $254.
benzinga.com Danaher Beats Profit Estimates, Raises Outlook as Customer Demand Improves Danaher topped Q3 earnings estimates at $2.11 per share on $6.55 billion revenue, raising its full-year 2026 adjusted EPS outlook on steady biopharma demand.
benzinga.com Meta, Tesla On Deck Wednesday As AI Spending, Auto Demand Face Test Meta Platforms and Tesla headline Wednesday’s reports, with investors focused on whether AI investment can keep driving growth while Tesla’s core auto business weakens. Philip Morris International,…
benzinga.com Danaher Q3 2026 Earnings Call Transcript Danaher (NYSE:DHR) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
benzinga.com Danaher Sees Q4 2026 Non-GAAP Core Revenue Excluding Respiratory Revenue Up 4%-5% YoY Danaher (NYSE:DHR) expects fourth quarter of 2026 non-GAAP core revenue, excluding respiratory revenue, to increase 4.0% to 5.0% year-over-year.
benzinga.com Meta Platforms, Tesla Could Swing More Than $100 Billion After Earnings Discover 9 stocks to watch ahead of Wednesday’s earnings, including Meta, Tesla and Lam Research, with options-implied moves reaching 7.42%.
benzinga.com 9 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com Danaher Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call Danaher will report Q3 earnings Oct. 21, with estimates of $1.92 EPS and $6.56B revenue; shares fell 1.1% despite bullish analyst targets.
benzinga.com Lam Research Could Swing $28.6 Billion After Earnings Discover 9 stocks with the biggest options-implied earnings moves, led by Spotify at 9.31%, as investors prepare for key quarterly results.
benzinga.com Danaher Brings NVIDIA AI Into Scientific Instruments in Push for Faster Discoveries Danaher shares rose premarket after announcing an AI partnership with NVIDIA. DHR reports Q3 earnings Oct. 21.
benzinga.com What's Going On With NVIDIA Stock Wednesday? NVIDIA edges higher in premarket trading as technical levels hold. Key support, resistance, and stock analysis updated for NVDA.
benzinga.com Morgan Stanley Maintains Overweight on Danaher, Raises Price Target to $240 Morgan Stanley analyst Kallum Titchmarsh maintains Danaher (NYSE:DHR) with a Overweight and raises the price target from $220 to $240.
benzinga.com TD Cowen Maintains Buy on Danaher, Raises Price Target to $255 TD Cowen analyst Dan Brennan maintains Danaher (NYSE:DHR) with a Buy and raises the price target from $236 to $255.
benzinga.com 10 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…- benzinga.com Barclays Maintains Overweight on Danaher, Raises Price Target to $255 Barclays analyst Luke Sergott maintains Danaher (NYSE:DHR) with a Overweight and raises the price target from $230 to $255.
- benzinga.com Danaher To Launch Its First AI-powered Autonomous Lab To Help Researchers Develop Custom Antibodies And Other Molecular Tools Faster And More Efficiently; Expected To Operate At Scale In Early 2027 The lab will combine artificial intelligence, robotics and technologies from several Danaher operating companies in one connected workflow. It is the first step in a broader Danaher initiative to…
- benzinga.com RBC Capital Maintains Outperform on Danaher, Raises Price Target to $250 RBC Capital analyst Dan Leonard maintains Danaher (NYSE:DHR) with a Outperform and raises the price target from $215 to $250.
- benzinga.com Guggenheim Maintains Buy on Danaher, Raises Price Target to $250 Guggenheim analyst Subbu Nambi maintains Danaher (NYSE:DHR) with a Buy and raises the price target from $200 to $250.
- benzinga.com 10 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com 10 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…- benzinga.com Danaher Appoints Julie Sawyer Montgomery As President, CEO, Effective Oct. 1, Succeeding Rainer Blair Danaher Corporation (NYSE: DHR) ("Danaher" or "the Company") announced that the Company's Board of Directors has appointed Julie Sawyer Montgomery as President and Chief Executive Officer and a
benzinga.com Billionaire Investor Dumps Thermo Fisher, Cuts Danaher As He Pares Life Sciences Tools Bets Dan Loeb reduced his Danaher stake and exited Thermo Fisher in Q1 2026 as the billionaire investor trimmed life sciences exposure.
benzinga.com Stock Of The Day: Is The Danaher Selloff Over? Danaher Corporation (DHR) shares may have experienced a seller's capitulation. There has also been bullish action in the stock.- benzinga.com Wells Fargo Maintains Equal-Weight on Danaher, Lowers Price Target to $195 Wells Fargo analyst Brandon Couillard maintains Danaher (NYSE:DHR) with a Equal-Weight and lowers the price target from $212 to $195.
benzinga.com TD Cowen Maintains Buy on Danaher, Lowers Price Target to $236 TD Cowen analyst Dan Brennan maintains Danaher (NYSE:DHR) with a Buy and lowers the price target from $240 to $236.- benzinga.com Stifel Maintains Buy on Danaher, Lowers Price Target to $220 Stifel analyst Daniel Arias maintains Danaher (NYSE:DHR) with a Buy and lowers the price target from $260 to $220.
- benzinga.com Guggenheim Maintains Buy on Danaher, Lowers Price Target to $200 Guggenheim analyst Subbu Nambi maintains Danaher (NYSE:DHR) with a Buy and lowers the price target from $235 to $200.
benzinga.com RBC Capital Maintains Outperform on Danaher, Raises Price Target to $215 RBC Capital analyst Dan Leonard maintains Danaher (NYSE:DHR) with a Outperform and raises the price target from $200 to $215.
benzinga.com Crude Oil Surges 2%; 3M Shares Gain After Q2 Results US stocks trade higher as Dow Jones gains over 350 points. Tech shares rise by 2% while consumer staples fall. 3M Co. sees 9% jump after strong earnings.
benzinga.com Micron Leads Memory-Stock Rally, Nasdaq 100 Tops 29,000: Stock Market Today Semiconductors led a broad rebound Tuesday as Micron, Western Digital and Sandisk surged. Nasdaq 100 rallies past 29,000 points.
benzinga.com Why Danaher Stock Just Tanked 14% Danaher stock plunges despite Q2 earnings beat as the company cuts its 2026 core revenue growth forecast. Read details.
benzinga.com Transcript: Danaher Q2 2026 Earnings Conference Call Danaher (NYSE:DHR) released second-quarter financial results and hosted an earnings call on Tuesday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call…- benzinga.com Danaher Posts Q2 Results, Joins Calix, Equifax And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session US stock futures up, Nasdaq 100 gains 1%. Danaher Corp (DHR) shares fall 10.1% in pre-market trading. Other stocks also decline.
benzinga.com Earnings Scheduled For July 21, 2026 Companies Reporting Before The Bell • Mueller Industries (NYSE:MLI) is projected to report quarterly earnings at $1.15 per share on revenue of $1.27 billion. • Valmont Industries (NYSE:VMI) is…
benzinga.com Intel Could Swing $61.4 Billion in Value After Earnings This Week Earnings season takes center stage next week with options markets pricing in big post-results moves. Benzinga selected top stocks to watch.
benzinga.com Qiagen M&A Fever Builds: KKR, EQT, Advent Explore Possible Takeover Private equity giants circle Qiagen (QGEN) with potential bids of $50/share. Get the details on the molecular diagnostics buyout.- benzinga.com 9 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
- benzinga.com Evercore ISI Group Maintains Outperform on Danaher, Lowers Price Target to $230 Evercore ISI Group analyst Vijay Kumar maintains Danaher (NYSE:DHR) with a Outperform and lowers the price target from $232 to $230.
- benzinga.com Masimo Receives FDA Clearance For Opioid-Induced Respiratory Depression Detection Capability Combined Into Its Radius VSM Masimo, a Danaher company and a specialty diagnostics solutions innovator of pulse oximetry and other patient monitoring solutions, today announced FDA 510(k) clearance for an opioid-induced…
benzinga.com This MarketAxess Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday Wall Street analysts changed outlook on top names like MKTX, PRCT, VOD, and JILL. See ratings page and analysts' views before buying MKTX stock.